While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results in earlier phases ...

President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines ...

The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...